TCL Archive In Brief: Six On NCA Serve Out Terms, No Successors in Sights DCBD Renamed With ‘Centers’ In Title February 9, 1990
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004